GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
The anorectic effects of liraglutide are mediated by glucagon-like peptide-1 receptors expressed on GABAergic neurons in the nucleus tractus solitarius.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although GLP-1R stimulation has been shown to modulate GABAergic signaling in the hippocampus and NTS (38–40), the effects of GLP-1R agonism on GABAergic synapses in the CeA and ILC, especially in the context of alcohol drinking, are unknown.”
From The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission (2023) · cites this paper as [40]
In the citing paper
“Recent mechanistic studies, primarily conducted in rodents, have identified a number of sites of direct action putatively mediating the effects of GLP-1-based AOMs on eating and body weight, including the area postrema and nucleus tractus solitarius (47‐49), locus coeruleus (50), hypothalamic arcuate (51, 52) and dorsomedial nuclei (53), and the lateral septal nucleus (54).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [49]
In the citing paper
“GLP-1R-expressing neuron populations in the AP, and at least some of the NTS, are clearly activated by GLP-1RAs and appear to mediate at least some of the effects of these drugs on satiation, satiety, and nausea/malaise (47‐49), likely by recruiting circuits which are endogenous targets of (supraphysiological) gut-derived GLP-1.”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [49]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970 · cited 2×
“One such class of drugs includes analogs of the endogenous satiety signal glucagonlike peptide-1 (GLP-1) (2).”
BackgroundThe arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · cited 10×
“In addition, the AP is one of the most c-Fos–responsive areas of the brain following peripheral liraglutide (21, 36), and it is possible that part of the observed neural activity within the NTS (34, 36) is secondary to AP GLP-1R activation.”
BackgroundMethodResultInfluential
Research works printed but not linked: 1
- 10.1002/(sici)1096-9861(19960923)373:3<309::aid-cne1>3.0.co;2-6 · DOI · Paper page
Cited by
GLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
“Moreover, a combination of adenoviral knockdown of the GLP1R and chemogenetic experiments revealed an essential role of hindbrain GABAergic neurons in the actions of liraglutide to reduce food intake and body weight in rats over 3 weeks [24].”
BackgroundRevisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
McLean, B. A., Wong, C. K., Campbell, J. E., Hodson, D. J., Trapp, S., & Drucker, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa032 · Cited by 289
“Cre rats to target GABAergic neurons (130).”
Central and peripheral GLP-1 systems independently suppress eating
Brierley, D. I., Holt, M. K., Singh, A., de Araujo, A., McDougle, M., Vergara, M., Afaghani, M. H., Lee, S. J., Scott, K., Maske, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00344-4 · Cited by 265
Area postrema cell types that mediate nausea-associated behaviors
Zhang, C., Kaye, J. A., Cai, Z., Wang, Y., Prescott, S. L., & Liberles, S. D. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.010 · Cited by 263
“Furthermore, these findings suggest at least a partial separation of neural pathways that mediate satiety and nausea to exendin-4, consistent with a model that feeding inhibition involves GLP1R neurons in several brain regions (Adams et al., 2018; Burmeister et al., 2017; Fortin et al., 2020; Ghosal et al., 2017; Sech…”
BackgroundBeyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Hammoud, R., & Drucker, D. J. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00783-3 · Cited by 244
“Consistent with these findings, selective targeting of GLP1R + neurons in the hypothalamus or hindbrain does not completely attenuate the weight-reducing actions of GLP1RAs in mice or rats 151,152 .”
Chuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214
Dissociable hindbrain GLP1R circuits for satiety and aversion
Huang, K.-P., Acosta, A. A., Ghidewon, M. Y., McKnight, A. D., Almeida, M. S., Nyema, N. T., Hanchak, N. D., Patel, N., Gbenou, Y. S. K., Adriaenssens, A. E., et al. (2024) · Nature · doi:10.1038/s41586-024-07685-6 · Cited by 166
“This finding aligns with work showing that AP lesion does not block the satiating effects of GLP1R ligands 39,44 .”
Kabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
“However, GABAergic neurons may not be completely dispensable as inhibition of hindbrain GABAergic neurons attenuates the food intake and body weight reducing effects of liraglutide in rats on a high fat diet (Fortin et al., 2020).”
BackgroundTanycytes control hypothalamic liraglutide uptake and its anti-obesity actions
Imbernon, M., Saponaro, C., Helms, H. C. C., Duquenne, M., Fernandois, D., Deligia, E., Denis, R. G. P., Chao, D. H. M., Rasika, S., Staels, B., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.06.002 · Cited by 124
Marty, V. N., Farokhnia, M., Munier, J. J., Mulpuri, Y., Leggio, L., & Spigelman, I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.599646 · Cited by 102
A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing
Dowsett, G. K. C., Lam, B. Y. H., Tadross, J. A., Cimino, I., Rimmington, D., Coll, A. P., Polex-Wolf, J., Knudsen, L. B., Pyke, C., & Yeo, G. S. H. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101240 · Cited by 98
“In addition to signalling to hypothalamic neurons, semaglutide and liraglutide have both been shown to activate GLP1R neurons within the AP and NTS, mediating some of these drugs’ weight loss effects [7,38].”
BackgroundDong, Y., Carty, J., Goldstein, N., He, Z., Hwang, E., Chau, D., Wallace, B., Kabahizi, A., Lieu, L., Peng, Y., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101352 · Cited by 93
“However, GABAergic neurons may not be completely dispensable as inhibition of hindbrain GABAergic neurons attenuates the food intake and body weight-reducing effects of Liraglutide in rats on a high-fat diet [72].”
BackgroundObesity and the kidney: mechanistic links and therapeutic advances
Yau, K., Kuah, R., Cherney, D. Z. I., & Lam, T. K. T. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00951-7 · Cited by 91
“Additional results indicate that the GLP1RA liraglutide is internalized upon binding to the GLP1R and alters hypo-thalamic neurons to affect energy balance 100 , while GLPR signalling in the nucleus of the solitary tract is necessary for liraglutide to reduce feeding and weight 101 .”
Dong, M., Wen, S., & Zhou, L. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s375559 · Cited by 90
“Other studies have mapped the action of GLP-1RAs, demonstrating that GABA neurons in the NTS express GLP-1 receptors and mediate the anorectic effects of liraglutide in rats.(36) However, a study of single-cell RNA sequencing in the brain shows that the presence of GLP-1R on BBB endothelial cells is negligible.”
BackgroundCosta, A., Ai, M., Nunn, N., Culotta, I., Hunter, J., Boudjadja, M. B., Valencia-Torres, L., Aviello, G., Hodson, D. J., Snider, B. M., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101407 · Cited by 79
“Since the AP and the NTS are readily accessible to GLP-1R ligands when administered systemically [4,19,28,29], we asked whether CCK neurons express GLP-1R.”
BackgroundCui, Q. N., Stein, L. M., Fortin, S. M., & Hayes, M. R. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15683 · Cited by 71
“Indeed, even within the NTS, recent reports have clearly indicated that glutamatergic (Adams et al., 2018) and GABAergic (Fortin et al., 2020) neurons expressing GLP-1Rs are both needed to observe full intake suppression following GLP-1 ligand delivery.”
BackgroundSelf-citationGLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti, G., Gomes Moreira, D., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 68
Farokhnia, M., Tazare, J., Pince, C. L., Bruns, N., Gray, J. C., Re, V. L., Fiellin, D. A., Kranzler, H. R., Koob, G. F., Justice, A. C., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188314 · Cited by 72
Merkel, R., Hernandez, N. S., Weir, V. R., Zhang, Y., Caffrey, A., Rich, M. T., Crist, R. C., Reiner, B. C., & Schmidt, H. D. (2025) · Science Advances · doi:10.1126/sciadv.adr5051 · Cited by 79
“Male and female transgenic Long-Evans rats ( Rattus norvegicus ) expressing Cre recombinase under the rat Gad1 promoter [LE-Tg(Gad1-iCre)3Ottc] were purchased from the Rat Resource and Research Center (RRRC P40OD011062; Columbia, MO) ( 15 , 68 , 69 ).”
Self-citationGuerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110303 · Cited by 62
Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for Satiety
Webster, A. N., Becker, J. J., Li, C., Schwalbe, D. C., Kerspern, D., Karolczak, E. O., Bundon, C., Onoharigho, R. A., Crook, M., Jalil, M., et al. (2023) · doi:10.1101/2023.10.31.564990 · Cited by 56
Zhang, F., Chen, Z., Wu, D., Tian, L., Chen, Q., Ye, Y., Chen, W., Wu, X., Wu, P., Yuan, W., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103382 · Cited by 54
Memory and eating: A bidirectional relationship implicated in obesity
Parent, M. B., Higgs, S., Cheke, L. G., & Kanoski, S. E. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.051 · Cited by 61
Molecular connectomics reveals a glucagon-like peptide 1-sensitive neural circuit for satiety
Webster, A. N., Becker, J. J., Li, C., Schwalbe, D. C., Kerspern, D., Karolczak, E. O., Bundon, C. B., Onoharigho, R. A., Crook, M., Jalil, M., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01168-8 · Cited by 55
“AgRP-Cre mice have an internal ribosome entry site (IRES)-Cre inserted after the stop codon of the Agrp gene on chromosome 8 (ref.”
Liraglutide restores impaired associative learning in individuals with obesity
Hanssen, R., Rigoux, L., Kuzmanovic, B., Iglesias, S., Kretschmer, A. C., Schlamann, M., Albus, K., Edwin Thanarajah, S., Sitnikow, T., Melzer, C., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00859-y · Cited by 52
“4Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.”
MethodInfluentialElectroceuticals in the Gastrointestinal Tract
Ramadi, K. B., Srinivasan, S. S., & Traverso, G. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.014 · Cited by 53
“Specific brain regions express hormonal receptors, suggesting that gut-brain communication is both neuronal and hormonal[93].”
BackgroundPark, J. S., Kim, K. S., & Choi, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0106 · Cited by 60
“GLP-1R is expressed in the AP and nucleus of the solitary tract (NTS) located in the hindbrain, and c-Fos expression after GLP-1RA injection was apparent in hindbrain GLP-1R cells, with further studies demonstrating these cells’ role in mediating GLP-1RA actions [59,96,102,103].”
Chen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178239 · Cited by 48
“The anorectic and nausea-inducing responses to these agents critically depend on the activation of GLP-1Rs within the central nervous system (CNS) (9–11, 23, 25, 26, 40, 57); whether these effects arise from different brain regions remains an open question.”
BackgroundInfluentialGut peptide regulation of food intake – evidence for the modulation of hedonic feeding
Woodward, O. R. M., Gribble, F. M., Reimann, F., & Lewis, J. E. (2022) · The Journal of Physiology · doi:10.1113/jp280581 · Cited by 40
“Similarly, knockdown of GLP-1R in the NTS attenuated the anorectic and body weight effect of liraglutide in acute and chronic studies; a chemogenetic strategy targeting a GABAergic population of neurons within the NTS which express GLP-1R replicated the effects (Fortin et al. 2020).”
BackgroundObesity pharmacotherapy: incretin action in the central nervous system
Boer, G. A., Hay, D. L., & Tups, A. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.11.001 · Cited by 52
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Jones, L. A., & Brierley, D. I. (2025) · Endocrinology · doi:10.1210/endocr/bqae167 · Cited by 43
Urkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 45
“The arcuate nucleus and nucleus of the solitary tract have been found to be involved in the regulation of appetite and food intake by liraglutide [88,96–98].”
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
Stemmer, K., Finan, B., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.008 · Cited by 43
“Peripheral administration of GLP-1RA stimulates neuronal activity in the hypothalamus [58,59] and in the brainstem [60].”
BackgroundGut-to-brain signals in feeding control
Moura‐Assis, A., Friedman, J. M., & Velloso, L. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00388.2020 · Cited by 46
GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans
Hanssen, R., Kretschmer, A. C., Rigoux, L., Albus, K., Edwin Thanarajah, S., Sitnikow, T., Melzer, C., Cornely, O. A., Brüning, J. C., & Tittgemeyer, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101163 · Cited by 40
“Peripherally administered liraglutide might bind to GLP-1 receptorexpressing glutamatergic and GABAergic neurons [93] as well as astrocytes [94,95] within the NTS, which regulate the GLP-1 producing neurons in the NTS.”
BackgroundInfluentialReiner, B. C., Zhang, Y., Stein, L. M., Perea, E. D., Arauco‐Shapiro, G., Nathan, J. B., Ragnini, K., Hayes, M. R., Ferraro, T. N., Berrettini, W. H., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02135-1 · Cited by 47
“Fluorescent in situ hybridization was conducted using the RNAscope, similar to our previously published studies [36, 37].”
Self-citationSingle-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
Ludwig, M. Q., Todorov, P. V., Egerod, K. L., Olson, D. P., & Pers, T. H. (2021) · Diabetes · doi:10.2337/dbi21-0003 · Cited by 38
Buller, S., & Blouet, C. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00250.2023 · Cited by 40
Milliken, B. T., Elfers, C., Chepurny, O. G., Chichura, K. S., Sweet, I. R., Borner, T., Hayes, M. R., Jonghe, B. C. D., Holz, G. G., Roth, C. L., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01783 · Cited by 41
Self-citationNeuroendocrine gut–brain signaling in obesity
Gruber, T., Lechner, F., Krieger, J.-P., & García‐Cáceres, C. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.05.002 · Cited by 44
A brainstem to hypothalamic arcuate nucleus GABAergic circuit drives feeding
de Morentin, P. B. M., González, J. A., Dowsett, G. K. C., Martynova, Y. V., Yeo, G. S. H., Sylantyev, S., & Heisler, L. K. (2024) · Current Biology · doi:10.1016/j.cub.2024.02.074 · Cited by 39
“(G-H) Quantification of number of interactions with a novel object, a known nutritional food item or a novel palatable food item in mice (G) non-stimulated (RM ANOVA (F(2,10)=4.”
BackgroundBakker, W., Imbernón, M., Salinas, C. G., Chao, D. H. M., Hassouna, R., Morel, C., Martin, C., Leger, C., Denis, R., Castel, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111698 · Cited by 38
Wen, S., Nguyen, T., Gong, M., Yuan, X., Wang, C., Jin, J., & Zhou, L. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s312527 · Cited by 30
Fortin, S. M., Chen, J. C., Petticord, M. C., Ragozzino, F. J., Peters, J. H., & Hayes, M. R. (2023) · Science Advances · doi:10.1126/sciadv.adh0980 · Cited by 32
“Rats were also tested with the GLP-1R antagonist, exendin (9-39) (Ex-9), to investigate an endogenous contribution of LC GLP-1R signaling to feeding behavior.”
BackgroundMethodSelf-citationWagner, S., Brierley, D. I., Leeson-Payne, A., Jiang, W., Chianese, R., Lam, B. Y. H., Dowsett, G. K. C., Cristiano, C., Lyons, D., Reimann, F., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101665 · Cited by 32
The diverse effects of brain glucagon‐like peptide 1 receptors on ingestive behaviour
Williams, D. L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15535 · Cited by 34
“However, in another report, AP lesions did not attenuate the effect of systemic liraglutide, the long-acting GLP-1 agonist (Fortin et al., 2020).”
BackgroundInfluentialEdvardsson, C. E., Cadeddu, D., Ericson, M., Adermark, L., & Jerlhag, E. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105684 · Cited by 33
Wean, J., Kowalsky, A. H., Laker, R., Will, S., Drucker, D. J., Rhodes, C. J., & Seeley, R. J. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102074 · Cited by 28
GLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 35
“However, selective NTS GLP-1R knockout attenuated chronic liraglutide-induced weight loss, while AP lesioning did not (84, 124).”
The (dys)regulation of energy storage in obesity
Levin, B. E., Geary, N., & Lutz, T. A. (2025) · Physiological Reviews · doi:10.1152/physrev.00002.2024 · Cited by 29
Effects of glucagon‐like peptide‐1 analogue treatment in genetic obesity: A case series
Welling, M. S., de Groot, C. J., Kleinendorst, L., van der Voorn, B., Burgerhart, J. S., van der Valk, E. S., van Haelst, M. M., van den Akker, E. L. T., & van Rossum, E. F. C. (2021) · Clinical Obesity · doi:10.1111/cob.12481 · Cited by 29
“of GLP-1 receptors on GABA neurons in the nucleus tractus solitarius or via direct activation of the periventricular neurons.(24,25) Moreover, functional magnetic resonance imaging has shown a decreased activity of appetite- and reward-related areas of the brain (insula, amygdala, orbitofrontal cortex and putamen) dur…”
BackgroundChrobok, Ł., Klich, J. D., Sanetra, A. M., Jeczmien‐Lazur, J. S., Pradel, K., Palus‐Chramiec, K., Kępczyński, M., Piggins, H. D., & Lewandowski, M. H. (2021) · The Journal of Physiology · doi:10.1113/jp281838 · Cited by 26
“For example, the peptides orexin and GLP-1 exert potent actions on neuronal activity in the DVC and function as preprandial and postprandial cues, respectively (Peyron et al. 1998; Yang & Ferguson, 2003; Yang et al. 2003; Richard et al. 2015; Fortin et al. 2020).”
BackgroundChichura, K. S., Elfers, C., Salameh, T. S., Kamat, V., Chepurny, O. G., McGivney, A., Milliken, B. T., Holz, G. G., Applebey, S. V., Hayes, M. R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-36178-1 · Cited by 27
Self-citationSeeking satiety: From signals to solutions
Tschöp, M. H., & Friedman, J. M. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adh4453 · Cited by 30
“In rats, knockdown of GLP1R in NTS neurons reduced the effect of liraglutide, and further studies suggested that GABAergic NTS neurons are the target ( 104 ).”
BackgroundDedic, N., Wang, L., Hajós‐Korcsok, É., Hecksher‐Sørensen, J., Roostalu, U., Vickers, S. P., Wu, S. S., Anacker, C., Synan, C., JONES, P. G., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101883 · Cited by 25
Zhang, A., Liu, Q., Xiong, Y., Li, J., Xu, Y., Song, H., Jing, X., Xu, H., Yang, N., Li, Y., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16294 · Cited by 22
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 27
“…such as liraglutide in animals are largely dependent on their action in the central nervous system (Adams et al ., 2018; Beiroa et al ., 2014; Sisley et al ., 2014; Fortin et al ., 2020), which requires GLP1R-mediated transport across the blood – brain barrier by tanycytes (Imbernon et al ., 2022).”
BackgroundMohr, S. M., Pra, R. D., Platt, M. P., Feketa, V. V., Shanabrough, M., Varela, L., Kristant, A., Cao, H., Merriman, D. K., Horváth, T. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49996-2 · Cited by 23
Xie, Z., Yang, Z., Tian, D., & Chen, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1618079 · Cited by 22
“When liraglutide binds to GLP-1R on GABAergic neurons in the NTS, it directly potentiates GABA release and suppresses food intake (Fortin et al., 2020).”
Listos, J., Listos, P., Baranowska-Bosiacka, I., Karpiuk, A., Filarowska, J., Łupina, M., Słowik, T., Zawiślak, S., & Kotlińska, J. (2022) · Molecules · doi:10.3390/molecules27082478 · Cited by 20
“Furthermore, it is known that GLP-1 receptors are located on GABAergic neurons, in the nucleus tractus solitarius [62] and in other brain areas [12,63,64], including the amygdala [12], and that their stimulation leads to GABA release [65].”
BackgroundRodríguez, R., Hergarden, A. C., Krishnan, S., Morales, M., Lam, D., Tracy, T., Tang, T., Patton, A., Lee, C. R., Pant, A., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102156 · Cited by 34
Tongta, S., Sungkaworn, T., & Pathomthongtaweechai, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210974 · Cited by 21
Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R
Zhang, H., Liu, Y., Cheng, L., Ma, X., & Luo, X. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.008 · Cited by 16
Central NPFF signalling is critical in the regulation of glucose homeostasis
Zhang, L., Koller, J., Gopalasingam, G., Qi, Y., & Herzog, H. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101525 · Cited by 15
Le, T. D. V., Liu, D., Besing, G.-L. K., Raghavan, R., Ellis, B. J., Ceddia, R. P., Collins, S., & Ayala, J. E. (2023) · eLife · doi:10.7554/elife.80944 · Cited by 16
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186652 · Cited by 12
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Hankir, M. K., & Lutz, T. A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03047-3 · Cited by 16
“On the other hand, inhibiting GLP-1R-expressing GABAergic neurons or deleting GLP-1Rs in the NTS alone is sufficient to partially prevent the appetite-suppressing and/ or weight-lowering effects of chronic systemic liraglutide in rats [54].”
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala
Duran, M., Willis, J. R., Dalvi, N., Fokakis, Z. N., VIRKUS, S., & Hardaway, J. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf019 · Cited by 13
Lavoie, O., Turmel, A., Mattoon, P., Desrosiers, W. J., Plamondon, J., Michael, N. J., & Caron, A. (2024) · Neuroendocrinology · doi:10.1159/000538716 · Cited by 12
Zhu, R., Tian, P., Zhang, H., Wang, G., & Chen, W. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109315 · Cited by 12
Turcano, P., Savica, R., & Benarroch, E. E. (2024) · Neurology · doi:10.1212/wnl.0000000000209781 · Cited by 16
GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and Memory
Gao, S., Décarie-Spain, L., Gu, C., Mazzini, G., Kanoski, S. E., & Borner, T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70129 · Cited by 17
Self-citationFortin, S. M., Chen, J., & Hayes, M. R. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112870 · Cited by 10
Self-citationGlucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits
Hwang, E., Portillo, B., & Williams, K. W. (2025) · Endocrinology · doi:10.1210/endocr/bqaf125 · Cited by 10
Glucagon-Like Peptide-1 Receptors in the Gustatory Cortex Influence Food Intake
Dossat, A. M., Kokoska, M. M., Whitaker‐Fornek, J. R., Sniffen, S. E., Kulkarni, A. S., Levitt, E. S., & Wesson, D. W. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1668-22.2023 · Cited by 10
Mukherjee, A., DiBrog, A. M., & Mietlicki‐Baase, E. G. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113869 · Cited by 8
Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment
Cao, Y., & Tong, Q. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100569 · Cited by 10
Sex differences in GLP-1 signaling across speciesPreprint
Roseberry, T., Grossrubatscher, I., Krausz, T., Wang, Y.-J., Schwartz, M. W., & Tingley, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.17.643822 · Cited by 8
Caffrey, A., Lavecchia, E., Chichura, K. S., Hayes, M. R., Doyle, R. P., & Schmidt, H. D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70096 · Cited by 7
“For example, GLP-1R agonists have been shown to alter glutamate and GABA transmission in the brain (Chuong et al., 2023; Fortin et al., 2020; Hernandez et al., 2021; Korol et al., 2015; Merkel et al., 2025; Mietlicki-Baase et al., 2013).”
Self-citationBaumer-Harrison, C., Aldaghma, D., White, A. D., Applebey, S. V., Pataro, A. M., Mohiby, A. Z., Alonso, B., Xiao, A. G., O’Farrell, L. S., Qian, Y., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70427 · Cited by 9
“32,34,36,37 Future studies should investigate additional brain circuitry potentially associated with GLP-1R biased agonism.”
Self-citationElfers, C., Chichura, K. S., Ashlaw, E. F., Chepurny, O. G., Holz, G. G., Doyle, R. P., & Roth, C. L. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.035 · Cited by 8
Edvardsson, C. E., Vestlund, J., Ericson, M., & Jerlhag, E. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1439203 · Cited by 7
Insights into the neurobiology of weight loss after bariatric surgery and GLP-1R agonists
Cook, T. M., Fuller, K. N. Z., & Sandoval, D. A. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110269 · Cited by 7
The interplay between hypothalamic and brainstem nuclei in homeostatic control of energy balance
Arčon, M. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115398 · Cited by 11
Zhou, F., Jiang, L., Guo, J., Fan, Y., Pan, Q., Li, T., Sun, X., & Li, P. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231161516 · Cited by 7
Hes, C., Tomlinson, A. J., Michielsen, L., Murdoch, H. J., Soltani, F., Kokoeva, M. V., & Sabatini, P. V. (2025) · eLife · doi:10.7554/elife.106217 · Cited by 9
“Such a reference atlas is also needed to contrast the cell types found within the mouse to other research models, including the rat, which are prominent models for DVC biology ( Ludwig et al., 2021 ; Fortin et al., 2020 ).”
Refractory Nausea and Vomiting Due to Central Nervous System Injury: A Focused Review
Stoica, S., Hogge, C. J., & Theeler, B. J. (2025) · Life · doi:10.3390/life15071021 · Cited by 6
Obesity and emerging intervention strategies: Mechanistic insights and novel drug targets
Feng, X., Li, S., Li, J., & Su, Z. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003919 · Cited by 7
“[107] Monoaminergic modulators, including phentermine and fluoxetine, suppress appetite by targeting hypothalamic satiety pathways, though their use may be limited by cardiovascular or psychiatric side effects [Figure 4].”
Yan, J., Hao, P.-L., Zeng, S.-M., Liang, C.-X., Chen, Y., Chen, K.-W., Qu, W., Zeng, X., Zhong, Z., & Zhang, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113585 · Cited by 8
Shen, J., Wang, M., Pang, G., Zhang, Y., Zhang, J., Shi, Y., Liu, J., & Zhan, C. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00528.2024 · Cited by 7
Applebey, S. V., Xiao, A. G., Harris, E. P., Levine, C. M., Belser, D. L., Geisler, C. E., Parent, M. B., Bangasser, D. A., Crist, R. C., Reiner, B. C., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.012 · Cited by 6
Self-citationDiabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions
Espinoza, L., & Boychuk, C. R. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.06.006 · Cited by 6
Synergistic effects of GABA and hypoglycemic drugs
Tyurenkov, I. N., Faibisovich, T. I., & Bakulin, D. A. (2023) · Problems of Endocrinology · doi:10.14341/probl13257 · Cited by 5
Gut–vagus–NTS neural pathway in controlling feeding behaviors
Chen, J. W., & Zhan, C. (2023) · Stress and Brain · doi:10.26599/sab.2023.9060033 · Cited by 6
Self-citationBashaw, A. G., Roman-Ortiz, C., Gao, S. X., Schier, L. A., Borner, T., & Kanoski, S. E. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.006 · Cited by 5
Self-citationBaumer-Harrison, C., Graham, M., Jonghe, B. C. D., & Hayes, M. R. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.015 · Cited by 8
Self-citationMedial hypothalamic MC3R signalling regulates energy rheostasis in adult mice
Possa‐Paranhos, I. C., Butts, J., Pyszka, E., Nelson, C., Congdon, S., Cho, D., & Sweeney, P. (2024) · The Journal of Physiology · doi:10.1113/jp286699 · Cited by 6
“The function of MC3R neurons in the DMH contrasts with the established role for DMH leptin receptor and DMH GLP1R neurons in suppressing feeding (Faber et al., 2021; Kim et al., 2024; Rupp et al., 2023; Tang et al., 2023), indicating functional specificity within distinct DMH cell types involved in energy homeostasis.”
InfluentialXu, Z., Wen, S., Dong, M., & Zhou, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16146 · Cited by 4
“41 Suc-ceeded explorations indicated that optogenetic stimulation of GABA DVC terminals could inhibit NPY ARC neurons.”
Cassano, D., Aguggia, J. P., Giovanini, L., Heredia, F., Francesco, P. N. D., Andreoli, M. F., Schöth, H. B., Habib, A. M., Fernández, G., & Perelló, M. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112627 · Cited by 3
GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease
Gandhi, A., Phyu, E. M., Koom‐Dadzie, K., Dickson, K. B., & Halm, J. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062853 · Cited by 6
“Experimental data indicate that the nucleus tractus solitarius is a key site of action, as selective GLP-1 receptor knockdown in this region attenuates the anorectic and weight-reducing effects of liraglutide [83,84].”
Metadata
- Authors
- Fortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Hayes, Matthew R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2020-03-04
- Volume
- 12
- Issue
- 533
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC7211411
- OpenAlex
- W3009862144
- Cited by
- 127
- References
- 118
- Citations by year
- 2026: 13 · 2025: 32 · 2024: 23 · 2023: 15 · 2022: 14 · 2021: 19 · 2020: 11
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH Office of the Director (DK115762, DA037897, DA045792)
- Novo Nordisk (IISP)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- GABAergic neurons, nucleus tractus solitarius, GLP-1 receptor, liraglutide, anorectic effect, dietary intake, body weight, chemogenetics, appetite regulation
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Liraglutide, Animals, Appetite Depressants, Eating, Male, Rats, Sprague-Dawley, In Situ Hybridization, Fluorescence, Solitary Nucleus, Rats, GABAergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.